COMPARISON OF RANIBIZUMAB AND AFLIBERCEPT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NAMD) USING A TREAT-AND-EXTEND REGIMEN: RESULTS OF THE 24-MONTH SECONDARY EFFICACY OUTCOMES FROM THE RIVAL STUDY, A RANDOMIZED CLINICAL TRIAL

Alex P. Hunyor, Jennifer Arnold, Ian L. McAllister, Francois L. Pecheur, Ronelle-Mare Heath, Robyn H. Guymer, Marc C. Gillies

Research output: Contribution to journalAbstract/Meeting Abstract

Original languageEnglish
Article numberS1502
Pages (from-to)42-42
Number of pages1
JournalClinical and Experimental Ophthalmology
Volume46
Publication statusPublished - Nov 2018

Cite this